106 related articles for article (PubMed ID: 10503965)
1. Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor.
Komatsu H; Amano M; Yamaguchi S; Sugahara K
Life Sci; 1999; 65(13):PL171-6. PubMed ID: 10503965
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
Komatsu H; Amano M
Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor.
Mizuki M; Komatsu H; Akiyama Y; Iwane S; Tsuda T
Life Sci; 1999; 65(20):2031-9. PubMed ID: 10579457
[TBL] [Abstract][Full Text] [Related]
4. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
[TBL] [Abstract][Full Text] [Related]
5. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
6. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
8. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
9. The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils.
Jawień J; Lomnicka M; Korbut R; Chłopicki S
J Physiol Pharmacol; 2005 Dec; 56(4):637-48. PubMed ID: 16391420
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.
Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG
J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480
[TBL] [Abstract][Full Text] [Related]
13. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
[TBL] [Abstract][Full Text] [Related]
14. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
15. The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes.
Svetlov SI; Barton JM; Olson MS
Life Sci; 1996; 58(5):PL 81-6. PubMed ID: 8594301
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils.
Kroegel C; Yukawa T; Westwick J; Barnes PJ
Biochem Biophys Res Commun; 1989 Jul; 162(1):511-21. PubMed ID: 2546554
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Giembycz MA; Kroegel C; Barnes PJ
J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor.
Komatsu H; Nagasawa M; Okumoto T
Int J Immunopharmacol; 1993 Aug; 15(6):737-44. PubMed ID: 7691768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
